THOC1 deficiency leads to late-onset nonsyndromic hearing loss through p53-mediated hair cell apoptosis

PLoS Genet. 2020 Aug 10;16(8):e1008953. doi: 10.1371/journal.pgen.1008953. eCollection 2020 Aug.

Abstract

Apoptosis of cochlear hair cells is a key step towards age-related hearing loss. Although numerous genes have been implicated in the genetic causes of late-onset, progressive hearing loss, few show direct links to the proapoptotic process. By genome-wide linkage analysis and whole exome sequencing, we identified a heterozygous p.L183V variant in THOC1 as the probable cause of the late-onset, progressive, non-syndromic hearing loss in a large family with autosomal dominant inheritance. Thoc1, a member of the conserved multisubunit THO/TREX ribonucleoprotein complex, is highly expressed in mouse and zebrafish hair cells. The thoc1 knockout (thoc1 mutant) zebrafish generated by gRNA-Cas9 system lacks the C-startle response, indicative of the hearing dysfunction. Both Thoc1 mutant and knockdown zebrafish have greatly reduced hair cell numbers, while the latter can be rescued by embryonic microinjection of human wild-type THOC1 mRNA but to significantly lesser degree by the c.547C>G mutant mRNA. The Thoc1 deficiency resulted in marked apoptosis in zebrafish hair cells. Consistently, transcriptome sequencing of the mutants showed significantly increased gene expression in the p53-associated signaling pathway. Depletion of p53 or applying the p53 inhibitor Pifithrin-α significantly rescued the hair cell loss in the Thoc1 knockdown zebrafish. Our results suggested that THOC1 deficiency lead to late-onset, progressive hearing loss through p53-mediated hair cell apoptosis. This is to our knowledge the first human disease associated with THOC1 mutations and may shed light on the molecular mechanism underlying the age-related hearing loss.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / genetics
  • Benzothiazoles / pharmacology
  • CRISPR-Associated Protein 9 / genetics
  • DNA-Binding Proteins / deficiency
  • DNA-Binding Proteins / genetics*
  • Deafness / genetics*
  • Deafness / pathology
  • Disease Models, Animal
  • Exome Sequencing
  • Gene Expression Regulation / drug effects
  • Gene Knockout Techniques
  • Hair Cells, Auditory / metabolism
  • Hair Cells, Auditory / pathology
  • Hair Cells, Auditory, Inner / metabolism*
  • Hair Cells, Auditory, Inner / pathology
  • Humans
  • Mice
  • Mutation
  • RNA, Guide, CRISPR-Cas Systems
  • RNA-Binding Proteins / genetics*
  • Signal Transduction / drug effects
  • Toluene / analogs & derivatives
  • Toluene / pharmacology
  • Tumor Suppressor Protein p53 / antagonists & inhibitors
  • Tumor Suppressor Protein p53 / genetics*
  • Zebrafish / genetics

Substances

  • Benzothiazoles
  • DNA-Binding Proteins
  • RNA-Binding Proteins
  • THOC1 protein, human
  • Tumor Suppressor Protein p53
  • Toluene
  • pifithrin
  • CRISPR-Associated Protein 9

Supplementary concepts

  • Nonsyndromic Deafness

Grants and funding

This work was supported by National Natural Science Foundation of China (www.nsfc.gov.cn) (81641155 and 81870725 to LP.Z; 81970894 to TY; 81730028 to HW; 2018YFA0801004 and 81870359 to DL; 81700920 to XP and 81600802 to RZ), Shanghai Municipal Science and Technology Commission (http://stcsm.sh.gov.cn) (14DZ2260300 to HW) and Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant (http://edu.sh.gov.cn/) (20152519 to TY), Nantong science and technology plan frontier and key technology innovation fund (kjj.nantong.gov.cn) (MS22015048 to LP.Z); and the Natural Science Foundation from Jiangsu Province (http://kxjst.jiangsu.gov.cn/) (BK20180048 and 17KJA180008) to DL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.